A case of fertility sparing surgery of low-Grade endometrial stromal sarcoma in young female

Low-grade endometrial stromal sarcoma (LGESS) is a rare malignancy. Total hysterectomy and bilateral salpingo-oophorectomy (BSO) were included in the main treatment. The present authors evaluate the feasibility of fertility-sparing management in a patient with low-grade ESS who desired childbearing. The patient aged 24 years presented without symptom. She received laparoscopic myomectomy with endobag morcellation of local resection of the mass with uterine reconstruction. The postoperative pathohistologic analysis showed estrogen receptor (±), progesterone receptor (+), then the adjuvant hormonal therapy was given with megestrol acetate 320 mg/day for six months. She received close follow-up which included clinical examination, tumor markers, abdominal and pelvic ultrasound, and yearly pelvic MRI. Thirty-five months after surgery, no evidence of recurrence was observed throughout this period. The authors propose that consider that fertility-sparing treatment is suitable in selected in young LGESS patients, especially for those whose lesion was with a clear borderline. Adjuvant endocrine therapy is recommended for about six months after operation.

Low-grade endometrial stromal sarcoma (LGESS); Laparoscopic myomectomy; Endobag morcellation; Fertility-sparing treatment

[1] Fekete P.S., Vellios F.: “The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases”. Int. J. Gynecol. Pathol., 1984, 3, 198.

[2] Clement P.B., Young R.H.: “Diffuse leiomyomatosis of the uterus: a report of four cases”. Int. J. Gynecol. Pathol., 1987, 6, 322.

[3] Whitlatch S.P., Meyer R.L.: “Recurrent endometrial stromal sarcoma resembling intravenous leiomyomatosis”. Gynecol. Oncol., 1987, 28, 121.

[4] Ma S.K., Zhang H.T., Wu L.Y., Liu L.Y., Li B.: “Treatment and prognosis of low-grade malignant endometrial stromal sarcoma”. Zhonghua Zhong Liu Za Zhi, 2007, 29, 74.

[5] Sciallis A.P., Bedroske P.P., Schoolmeester J.K., Sukov W.R., Keeney G.L., Hodge J.C., et al.: “High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features”. Am. J. Surg. Pathol., 2014, 38, 1161.

[6] Styron S.L., Burke T.W., Linville W.K.: “Low-grade endometrial stromal sarcoma recurring over three decades”. Gynecol. Oncol., 1989, 35, 275.

[7] Delaney A.A., Gubbels A.L., Remmenga S., Tomich P., Molpus K.: “Successful pregnancy after fertility-sparing local resection and uterine reconstruction for low-grade endometrial stromal sarcoma”. Obstet. Gynecol., 2012, 120, 486.

[8] Bai H., Yang J., Cao D., Huang H., Xiang Y., Wu M., et al.: “Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases”. Gynecol. Oncol., 2014, 132, 654.

[9] Park J.Y., Kim K.R., Nam J.H.: “Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma”. Int. J. Gynecol. Cancer, 2013, 23, 81.

[10] Koskas M., Morice P., Yazbeck C., Duvillard P., Walker F., Madelenat P.: “Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence”. Anticancer Res., 2009, 29, 4147.

[11] Jin Y., Li Y., Deng C.Y., Tian Q.J., Chen H., Pan L.Y.: “Fertilitysparing treatment of low-grade endometrial stromal sarcoma”. Int. J. Clin. Exp. Med., 2015, 8, 5818.

[12] Nakamura K., Nakayama K., Ishikawa M., Ishikawa N., Katagiri H., Katagiri A., et al.: “Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: A case report and review of the literature”. Oncol. Lett., 2016, 12, 3856.